No abstract available
Publication types
-
Editorial
-
Research Support, Non-U.S. Gov't
-
Comment
MeSH terms
-
Antibiotics, Antineoplastic / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Biomarkers, Tumor / analysis*
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / enzymology
-
Breast Neoplasms / mortality
-
Chemotherapy, Adjuvant
-
Cyclophosphamide / administration & dosage
-
Disease-Free Survival
-
Epirubicin / administration & dosage
-
ErbB Receptors / analysis
-
Female
-
Fluorouracil / administration & dosage
-
Gene Expression Regulation, Neoplastic
-
Humans
-
Methotrexate / administration & dosage
-
Patient Selection*
-
Receptor Protein-Tyrosine Kinases / analysis*
-
Receptor, ErbB-2 / analysis
-
Receptor, ErbB-3 / analysis
-
Receptor, ErbB-4
-
Survival Analysis
-
Time Factors
-
Treatment Outcome
Substances
-
Antibiotics, Antineoplastic
-
Biomarkers, Tumor
-
Epirubicin
-
Cyclophosphamide
-
EGFR protein, human
-
ERBB2 protein, human
-
ERBB4 protein, human
-
ErbB Receptors
-
Receptor Protein-Tyrosine Kinases
-
Receptor, ErbB-2
-
Receptor, ErbB-3
-
Receptor, ErbB-4
-
Fluorouracil
-
Methotrexate